Panel Discussion: Evaluating Opportunities to Improve Long-Term Weight Loss Management

• Decreasing BMI and pricing barriers to patient access of obesity and weight loss medication
• Exploring therapeutic and non-therapeutic methods to ensure weight maintenance beyond initial therapeutic application

Speakers:

Xavier Jacq

Chief Scientific Officer

MitoRx Therapeutics Limited

Steffen-Sebastian Bolz

Executive Board Member and Chief Scientific Officer

APHAIA Pharma AG

Brent Meadows

Chief Business Officer

Senovia Biosciences